adverse drug reactions
Room for improvement in ADR reporting
Australia needs to adopt a robust and standardised pharmacovigilance system to improve adverse drug reaction reporting, researchers believe. A review of reporting, monitoring and handling of ADRs in Australia, published …
Looking at the numbers
Reports show 19 deaths occurred due to sildenafil in the UK last year. What does this mean for the medicine, which is being considered for S3 status in Australia? Data from …
Lack of remuneration, time an issue for reporting
A study has found community pharmacists have ‘suboptimal’ knowledge on reporting adverse drug reactions, making up only 6% of reports in 2017 Community pharmacists need more training on adverse drug …
Research Roundup
Debbie Rigby rounds up the latest in research news Update on colchicine, 2017 Colchicine is currently approved for the treatment of gout. Studies indicate that it may be beneficial in …
Recognising severe skin drug reactions
An MJA article looks at severe cutaneous drug reactions – a major cause of both morbidity and mortality in Australia There are key diagnostic figures that present early with severe …
‘Myths and outdated information’ still vaccine barriers
Vaccine safety continues to be a major concern for parents, a study about vaccination consumer concerns has found Published on Wednesday in the Australian and New Zealand Journal of Public …
10 key points: Deprescribing
An emerging health researcher and award-winning academic pharmacist speaks with AJP about the deprescribing process Dr Emily Reeve, from the Kolling Institute at Royal North Shore Hospital in Sydney, is …